Prevnar, the first pneumococcal vaccine for children under 2

The FDA just approved Prevnar, the first pneumococcal vaccine for children under 2.

This is important. Children under 2 have the highest risk of invasive pneumococcal disease.

Prevnar targets seven strains of pneumococcus. These strains account for approx 80% of invasive disease in children under 6.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote